It is therefore possible that treatment of FOXO3-Cyt-type gastric cancer with a PI3K-AKT inhibitor is effective for suppressing the survival or proliferation through the nuclear translocation of FOXO3. The gene discussed is AKT1; the disease is gastric cancer.